ATAIBECKLEY INC (9VC.DE) Fundamental Analysis & Valuation

FRA:9VC • NL0015000DX5

Current stock price

3.426 EUR
-0.04 (-1.21%)
Last:

This 9VC.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. 9VC.DE Profitability Analysis

1.1 Basic Checks

  • In the past year 9VC has reported negative net income.
  • 9VC had a negative operating cash flow in the past year.
  • 9VC had negative earnings in each of the past 5 years.
  • In the past 5 years 9VC always reported negative operating cash flow.
9VC.DE Yearly Net Income VS EBIT VS OCF VS FCF9VC.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -62.24%, 9VC is doing worse than 83.64% of the companies in the same industry.
  • The Return On Equity of 9VC (-93.44%) is worse than 80.00% of its industry peers.
Industry RankSector Rank
ROA -62.24%
ROE -93.44%
ROIC N/A
ROA(3y)-52.42%
ROA(5y)-70.02%
ROE(3y)-67.79%
ROE(5y)-86.99%
ROIC(3y)N/A
ROIC(5y)N/A
9VC.DE Yearly ROA, ROE, ROIC9VC.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for 9VC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
9VC.DE Yearly Profit, Operating, Gross Margins9VC.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -20K -40K -60K

8

2. 9VC.DE Health Analysis

2.1 Basic Checks

  • 9VC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, 9VC has more shares outstanding
  • The number of shares outstanding for 9VC has been increased compared to 5 years ago.
  • The debt/assets ratio for 9VC is higher compared to a year ago.
9VC.DE Yearly Shares Outstanding9VC.DE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
9VC.DE Yearly Total Debt VS Total Assets9VC.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • 9VC has an Altman-Z score of 5.29. This indicates that 9VC is financially healthy and has little risk of bankruptcy at the moment.
  • 9VC has a Altman-Z score of 5.29. This is in the better half of the industry: 9VC outperforms 76.36% of its industry peers.
  • There is no outstanding debt for 9VC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.29
ROIC/WACCN/A
WACC7.43%
9VC.DE Yearly LT Debt VS Equity VS FCF9VC.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 7.90 indicates that 9VC has no problem at all paying its short term obligations.
  • 9VC's Current ratio of 7.90 is amongst the best of the industry. 9VC outperforms 98.18% of its industry peers.
  • 9VC has a Quick Ratio of 7.90. This indicates that 9VC is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of 9VC (7.90) is better than 98.18% of its industry peers.
Industry RankSector Rank
Current Ratio 7.9
Quick Ratio 7.9
9VC.DE Yearly Current Assets VS Current Liabilites9VC.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. 9VC.DE Growth Analysis

3.1 Past

  • The earnings per share for 9VC have decreased by 0.00% in the last year.
  • Looking at the last year, 9VC shows a decrease in Revenue. The Revenue has decreased by -1.91% in the last year.
  • Measured over the past years, 9VC shows a very negative growth in Revenue. The Revenue has been decreasing by -75.28% on average per year.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75%
Revenue 1Y (TTM)-1.91%
Revenue growth 3Y-75.28%
Revenue growth 5YN/A
Sales Q2Q%1772.5%

3.2 Future

  • 9VC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.08% yearly.
  • 9VC is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 234.05% yearly.
EPS Next Y30.67%
EPS Next 2Y22.22%
EPS Next 3Y14.8%
EPS Next 5Y14.08%
Revenue Next Year468.25%
Revenue Next 2Y-38.09%
Revenue Next 3Y24.11%
Revenue Next 5Y234.05%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
9VC.DE Yearly Revenue VS Estimates9VC.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B 2.5B
9VC.DE Yearly EPS VS Estimates9VC.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 4

0

4. 9VC.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • 9VC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for 9VC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
9VC.DE Price Earnings VS Forward Price Earnings9VC.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
9VC.DE Per share data9VC.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as 9VC's earnings are expected to grow with 14.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.22%
EPS Next 3Y14.8%

0

5. 9VC.DE Dividend Analysis

5.1 Amount

  • 9VC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

9VC.DE Fundamentals: All Metrics, Ratios and Statistics

ATAIBECKLEY INC

FRA:9VC (12/30/2025, 7:00:00 PM)

3.426

-0.04 (-1.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-12
Earnings (Next)03-16
Inst Owners12.45%
Inst Owner ChangeN/A
Ins Owners3.7%
Ins Owner ChangeN/A
Market Cap1.24B
Revenue(TTM)308.00K
Net Income(TTM)-149.27M
Analysts83.33
Price Target10.49 (206.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-74.59%
Min EPS beat(2)-131.54%
Max EPS beat(2)-17.64%
EPS beat(4)1
Avg EPS beat(4)-48.58%
Min EPS beat(4)-131.54%
Max EPS beat(4)17.15%
EPS beat(8)3
Avg EPS beat(8)-34.15%
EPS beat(12)6
Avg EPS beat(12)-5.69%
EPS beat(16)8
Avg EPS beat(16)-13.8%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.74%
PT rev (3m)7.46%
EPS NQ rev (1m)-0.13%
EPS NQ rev (3m)-1.83%
EPS NY rev (1m)0%
EPS NY rev (3m)-29.5%
Revenue NQ rev (1m)-11.11%
Revenue NQ rev (3m)18.52%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)29.19%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4703.25
P/FCF N/A
P/OCF N/A
P/B 9.07
P/tB 9.26
EV/EBITDA N/A
EPS(TTM)-0.7
EYN/A
EPS(NY)-0.4
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS0
BVpS0.38
TBVpS0.37
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -62.24%
ROE -93.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-52.42%
ROA(5y)-70.02%
ROE(3y)-67.79%
ROE(5y)-86.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1203.88%
Cap/Sales 3521.75%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.9
Quick Ratio 7.9
Altman-Z 5.29
F-Score4
WACC7.43%
ROIC/WACCN/A
Cap/Depr(3y)268.35%
Cap/Depr(5y)673.01%
Cap/Sales(3y)220.74%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75%
EPS Next Y30.67%
EPS Next 2Y22.22%
EPS Next 3Y14.8%
EPS Next 5Y14.08%
Revenue 1Y (TTM)-1.91%
Revenue growth 3Y-75.28%
Revenue growth 5YN/A
Sales Q2Q%1772.5%
Revenue Next Year468.25%
Revenue Next 2Y-38.09%
Revenue Next 3Y24.11%
Revenue Next 5Y234.05%
EBIT growth 1Y18.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-5.8%
EBIT Next 3Y-18.5%
EBIT Next 5Y-6.5%
FCF growth 1Y3.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.22%
OCF growth 3YN/A
OCF growth 5YN/A

ATAIBECKLEY INC / 9VC.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ATAIBECKLEY INC (9VC.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to 9VC.DE.


What is the valuation status for 9VC stock?

ChartMill assigns a valuation rating of 0 / 10 to ATAIBECKLEY INC (9VC.DE). This can be considered as Overvalued.


How profitable is ATAIBECKLEY INC (9VC.DE) stock?

ATAIBECKLEY INC (9VC.DE) has a profitability rating of 0 / 10.